AU2001237992A1 - Purification of oligonucleotides - Google Patents

Purification of oligonucleotides

Info

Publication number
AU2001237992A1
AU2001237992A1 AU2001237992A AU3799201A AU2001237992A1 AU 2001237992 A1 AU2001237992 A1 AU 2001237992A1 AU 2001237992 A AU2001237992 A AU 2001237992A AU 3799201 A AU3799201 A AU 3799201A AU 2001237992 A1 AU2001237992 A1 AU 2001237992A1
Authority
AU
Australia
Prior art keywords
oligonucleotides
purification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001237992A
Inventor
Achim H. Krotz
Vasulinga T. Ravikumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU2001237992A1 publication Critical patent/AU2001237992A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
AU2001237992A 2000-01-31 2001-01-30 Purification of oligonucleotides Abandoned AU2001237992A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/495,398 US6586586B1 (en) 2000-01-31 2000-01-31 Purification of oligonucleotides
US09495398 2000-01-31
PCT/US2001/002951 WO2001055160A1 (en) 2000-01-31 2001-01-30 Purification of oligonucleotides

Publications (1)

Publication Number Publication Date
AU2001237992A1 true AU2001237992A1 (en) 2001-08-07

Family

ID=23968503

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001237992A Abandoned AU2001237992A1 (en) 2000-01-31 2001-01-30 Purification of oligonucleotides

Country Status (7)

Country Link
US (2) US6586586B1 (en)
EP (1) EP1252173A4 (en)
JP (1) JP2003531827A (en)
KR (1) KR20030032915A (en)
AU (1) AU2001237992A1 (en)
CA (1) CA2398749A1 (en)
WO (1) WO2001055160A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7351249B2 (en) * 1998-11-06 2008-04-01 Neomend, Inc. Systems, methods, and compositions for achieving closure of suture sites
US7279001B2 (en) * 1998-11-06 2007-10-09 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
US6899889B1 (en) * 1998-11-06 2005-05-31 Neomend, Inc. Biocompatible material composition adaptable to diverse therapeutic indications
US6830756B2 (en) * 1998-11-06 2004-12-14 Neomend, Inc. Systems, methods, and compositions for achieving closure of vascular puncture sites
CN101104594A (en) * 2002-12-26 2008-01-16 盐野义制药株式会社 Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure
US20050112625A1 (en) * 2003-08-22 2005-05-26 Konica Minolta Medical & Graphic, Inc. DNA amplification method
CN100416389C (en) * 2004-11-29 2008-09-03 友达光电股份有限公司 Liquid crystal display and its producing method
KR20130143675A (en) * 2005-01-28 2013-12-31 기린두스 악티엔게젤샤프트 Purification of oligonucleotides
KR100850430B1 (en) 2006-12-11 2008-08-05 (주)바이오니아 Method for isolating a nucleic acid using particulate matter and a compositions therefor
GB201115218D0 (en) 2011-09-02 2011-10-19 Glaxo Group Ltd Novel process
GB201612011D0 (en) 2016-07-11 2016-08-24 Glaxosmithkline Ip Dev Ltd Novel processes for the production of oligonucleotides
GB201721307D0 (en) 2017-12-19 2018-01-31 Glaxosmithkline Ip Dev Ltd Novel processes for the production of oligonucleotides
WO2021178295A1 (en) 2020-03-03 2021-09-10 University Of Washington Synthetic agonists of dna-pk and their use
KR20220167282A (en) * 2020-04-14 2022-12-20 스미또모 가가꾸 가부시끼가이샤 Compositions comprising nucleic acid oligomers
CN115362163A (en) * 2020-04-14 2022-11-18 住友化学株式会社 Method for producing nucleic acid oligomer
WO2023194537A1 (en) 2022-04-08 2023-10-12 Glaxosmithkline Intellectual Property Development Limited Novel processes for the production of polynucleotides including oligonucleotides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3433649A1 (en) * 1984-09-13 1986-03-20 Gesellschaft für Biotechnologische Forschung mbH (GBF), 3300 Braunschweig METHOD FOR PURIFYING SYNTHETIC OLIGONUCLEOTIDES
US4947927A (en) * 1989-11-08 1990-08-14 Pcc Airfoils, Inc. Method of casting a reactive metal against a surface formed from an improved slurry containing yttria
WO1992007951A1 (en) 1990-10-19 1992-05-14 Yoke Wah Kow Quantitation of aldehyde-containing lesions in nucleic acids

Also Published As

Publication number Publication date
US6586586B1 (en) 2003-07-01
KR20030032915A (en) 2003-04-26
JP2003531827A (en) 2003-10-28
CA2398749A1 (en) 2001-08-02
EP1252173A1 (en) 2002-10-30
US20030153742A1 (en) 2003-08-14
WO2001055160A1 (en) 2001-08-02
EP1252173A4 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
AU2001293188A1 (en) Water purifying kits
AU2001285009A1 (en) Water purification system
AU2001237992A1 (en) Purification of oligonucleotides
AU2001259501A1 (en) Continuous liquid purification process
AU2001281275A1 (en) Processes for the preparation of oligonucleotides
AU2001274571A1 (en) Micro-array of organism-associated substance
AU2001266225A1 (en) Decondensation of dna
AU2002231206A1 (en) Treatment of depression
AU2001244687A1 (en) Micro-array
AU2001267632A1 (en) Effluent purifying device
GB0011186D0 (en) Modification of bacteria
AU2002245107A1 (en) Improved biochip
AU2001294258A1 (en) Method of purifying plavastatin
AU2002310296A1 (en) Rna purification methods
AU2002214868A1 (en) Therapeutic oligonucleotides of reduced toxicity
AU2001295841A1 (en) Human dna sequences
AU2001271444A1 (en) Purification means
AU2001284741A1 (en) Method for purification of acarbose
SG106636A1 (en) Purification of methylsilanes
AU2001264931A1 (en) High-throughput purification process
IL138175A0 (en) Purification of hexafluoroethane
AU2001273348A1 (en) Purification of human troponin i
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002236439A1 (en) Purification of argon
AU2765001A (en) Purification of microglial cells